Literature DB >> 2911008

Demonstration of immunoreactive sites on cartilage after in vivo administration of biotinylated anti-type II collagen antibodies.

R Jonsson1, A L Karlsson, R Holmdahl.   

Abstract

Administration of biotinylated monoclonal antibodies provides the basis of a simple technique for identifying immunoreactive sites in vivo. Biotinylated anti-type II collagen antibodies were injected intraperitoneally into normal DBA/1 mice. The mice were sacrificed after 96 hr and the front paws removed and decalcified to allow tissue sectioning before snap-freezing. Binding of antibodies in vivo was visualized with affinity cytochemical staining using avidin-biotin-peroxidase complexes. Specific binding of antibodies to cartilaginous structures was seen after injection of 20-500 micrograms biotinylated monoclonal or polyclonal anti-type II collagen antibodies, but not after injection of a biotinylated control antibody. This technique should further the detection and localization studies of tissue components involved in the dynamics of physiological and pathological processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2911008     DOI: 10.1177/37.2.2911008

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  4 in total

1.  The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis.

Authors:  M Verdrengh; W Kum; A Chow; A Tarkowski
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity.

Authors:  Stefan Carlsen; Kutty Selva Nandakumar; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

3.  Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons.

Authors:  Alex Bersellini Farinotti; Gustaf Wigerblad; Diana Nascimento; Rikard Holmdahl; Camilla I Svensson; Duygu B Bas; Carlos Morado Urbina; Kutty Selva Nandakumar; Katalin Sandor; Bingze Xu; Sally Abdelmoaty; Matthew A Hunt; Kristina Ängeby Möller; Azar Baharpoor; Jon Sinclair; Kent Jardemark; Johanna T Lanner; Ia Khmaladze; Lars E Borm; Lu Zhang; Fredrik Wermeling; Mark S Cragg; Johan Lengqvist; Anne-Julie Chabot-Doré; Luda Diatchenko; Inna Belfer; Mattias Collin; Kim Kultima; Birgitta Heyman; Juan Miguel Jimenez-Andrade; Simone Codeluppi
Journal:  J Exp Med       Date:  2019-06-13       Impact factor: 14.307

4.  (Auto)immunity to cartilage matrix proteins - a time bomb?

Authors:  Raimund W Kinne
Journal:  Arthritis Res Ther       Date:  2013-01-21       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.